Search Results - "Oliva, E N"

A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes by Platzbecker, U, Symeonidis, A, Oliva, E N, Goede, J S, Delforge, M, Mayer, J, Slama, B, Badre, S, Gasal, E, Mehta, B, Franklin, J

“…The use of darbepoetin alfa to treat anemia in patients with lower-risk myelodysplastic syndromes (MDS) was evaluated in a phase 3 trial. Eligible patients had…”
Get full text

Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency by Salek, M. S., Ionova, T., Johns, J. R., Oliva, E. N.

“…Purpose Pyruvate kinase deficiency (PKD) is a rare disease and understanding of its epidemiology and associated burden remains limited. With no current…”
Get full text

P1705: PATIENT‐REPORTED OUTCOMES IN MYELOPROLIFERATIVE NEOPLASMS IN CLINICAL TRIALS: A SYSTEMATIC REVIEW by Oliva, E. N., Salek, S., Laane, E., Andreas, M., Csenar, M., Skoetz, N., Ionova, T.

Get full text

The IPSS-R has prognostic impact in untreated patients with MDS del(5q) by Kaivers, J., Lauseker, M., Hildebrandt, B., Fenaux, P., Pfeilstöcker, M., Valent, P., Platzbecker, U., Latagliata, R., Oliva, E.N., Xicoy, B., Götze, K., Ganster, C., Haase, D., Bug, G., Kündgen, A., Gattermann, N., Haas, R., Germing, U.

“…•The IPSS-R is validated as a prognostic tool for patients with MDS and del(5q).•Isolated del(5q) plus one non-chromosome 7 aberration deteriorates the…”
Get full text

P571: ORAL AZACITIDINE VS MIDOSTAURIN AS MAINTENANCE TREATMENT FOR FLT3 MUTANT ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION: AN INDIRECT TREATMENT COMPARISON by Oliva, E. N., Chen, C., Rahim, S. N., Seuro, B., Vasconcelos, A., Gaugler, L., Skikne, B., Prebet, T., Cameron, H., Beach, C., Thompson, G.

Get full text

P1725: OBSERVATIONAL STUDY TO EVALUATE PATIENT‐REPORTED OUTCOMES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA by Urciuoli, E., Di Bona, E., Greve, S., De Vivo, A., Sica, S., Fontana, R., Barcellini, W., Marano, L., Oliva, E. N.

Get full text

P564: FINAL RESULTS OF THE QOLESS AZA‐AMLE RANDOMIZED TRIAL TO EVALUATE THE EFFICACY OF 5‐AZA FOR POST‐REMISSION THERAPY OF ACUTE MYELOID LEUKEMIA IN ELDERLY PATIENTS by Oliva, E. N., Salutari, P., Di Raimondo, F., Reda, G., Capelli, D., Iannì, G., Tripepi, G., Alati, C., Mammì, C., D'Errigo, M. G., Niscola, P., Selleri, C., Musto, P., Vigna, E., Volpe, A., Cascavilla, N., Cannatà, M. C., Mannina, D., Candoni, A.

Get full text

Twice-weekly high-dose rHuEpo for the treatment of anemia in patients with low-risk myelodysplastic syndromes by Latagliata, R, Oliva, E N, Volpicelli, P, Carmosino, I, Breccia, M, Vincelli, I, Alati, C, Napoleone, L, Vozella, F, Nobile, F, Alimena, G

Get more information

Quality of life in elderly patients with acute myeloid leukemia: patients may be more accurate than physicians by OLIVA, Esther N, NOBILE, Francesco, PASTORE, Domenico, ALATI, Caterina, LATAGLIATA, Roberto, ALIMENA, Giuliana, RONCO, Francesca, SPECCHIA, Giorgina, IMPERA, Stefana, BRECCIA, Massimo, VINCELLI, Lolanda, CARMOSINO, Ida, GUGLIELMO, Patrizia

“…The aim of this study was to evaluate changes in quality of life scores and their association with therapy and survival in unselected elderly patients with…”
Get full text

Managing Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria: A Patient-Focused Perspective by Fattizzo, Bruno, Cavallaro, Francesca, Oliva, Esther Natalie, Barcellini, Wilma

“…The most frequently reported symptom in patients with paroxysmal nocturnal hemoglobinuria (PNH), a disease characterized by complement mediated hemolysis and…”
Get full text

Hemoglobin level threshold for cardiac remodeling and quality of life in myelodysplastic syndrome by Oliva, Esther Natalie, Dimitrov, Borislav D., Benedetto, Frank, D’Angelo, Arianna, Nobile, Francesco

“…Treatment of myelodysplastic syndrome (MDS) with epoietin is costly. However, cardiac morbidity associated with anemia has not been investigated in MDS. We…”
Get full text

More concern about transfusion requirement when evaluating quality of life in anemic patients by Oliva, Esther N, D'Angelo, Arianna, Martino, Bruno, Nobile, Francesco, Dimitrov, Borislav D, Perna, Annalisa

Get full text

P-76 Hemoglobin level threshold in myelodysplastic syndrome: Cardiac hypertrophy and quality of life by Oliva, E.N., Benedetto, F., Dimitrov, B., D'Angelo, A., Nobile, F.

Get full text

P-84 Darbepoetin alpha efficacy in myelodysplastic syndrome by Oliva, E.N., Ronco, F., Danova, M., Rovati, B., Dimitrov, B., Alati, C., Vincelli, I., Nobile, F.

Get full text

Quality of life in myelofibrosis with myeloid metaplasia: a cross-sectional study by Oliva, Esther N, Dimitrov, Borislav D, D’Angelo, Arianna, Perna, Annalisa, Nobile, Francesco

Get full text

Contribution to epicardial electrocardiography: tracing obtained by cardiac liberation in Pick's syndrome by ADORNI, O E, MARTINEZ, D J, HERNANDORENA, P, ROUCO OLIVA DE MARTINEZ, N, ADORNI, E

Get more information

Intramuscular strophanthin in clinical medicine by MARTINEZ, D J, ROUCO OLIVA DE MARTINEZ, N

Get more information

Importance of valvular plane in cardiac hemodynamics; doctrine by MARTINEZ, D J, ROUCO OLIVA DE MARTINEZ, N

Get more information

Biliary dyschezia by MARTINEZ, D J, ROUCO OLIVA DE MARTINEZ, N

Get more information